Everand Logo

Welcome to Everand!

  • STAT

    Azar, striking an aggressive tone, suggests Trump will call out drug companies behind major price hikes

    Health and Human Services Secretary Alex Azar suggested that President Trump would be quick to call out individual drug companies in the future.
    by Lev Facher May 14, 2018 2 minutes
    HHS Secretary Alex Azar

    WASHINGTON — Days after President Trump delivered a speech on prescription drug prices that was notably light on criticism of the pharmaceutical industry, his health secretary on Monday struck a far more aggressive tone, warning that the administration would be “turning on the pressure” on drug makers.

    The American public, Health and Human Services Secretary Alex Azar

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About Sanofi Licensing Novavax’s Covid Shot, Moderna’s RSV Vaccine, And More
    Sanofi said it has reached a licensing deal to sell Novavax’s Covid shot as well as to try to combine the vaccine with Sanofi’s own flu vaccine.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About Pfizer’s DTC Platform, Sandoz’s Feud With A U.K. Trade Group, And More
    Pfizer filed a trademark application last month for a website and app providing medical information and mail-order pharmacy and telehealth services to U.S. patients.
    STAT1 min read
    STAT+: Element Biosciences, An Illumina Rival, On Its Genomics Ambitions — And Why It Hasn’t Gone Public
    Element Biosciences' modest growth comes at a time when some other players are struggling in a sequencer market dominated by Illumina.

    Related Books & Audiobooks